By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
A drug called rosuvastatin is used to decrease high blood triglyceride and cholesterol levels. It is a member of the statin medication family that lowers cholesterol by blocking a liver enzyme involved in the production of cholesterol.
Rosuvastatin aids in lowering levels of LDL (bad cholesterol) and raising levels of HDL (good cholesterol) by reducing the quantity of cholesterol generated.
People with high cholesterol who are at risk for cardiovascular illness, such as a heart attack or stroke, are frequently administered rosuvastatin. It is typically advised together with a healthy diet and exercise routine and is taken orally in the form of a pill.
As with many medicines, rosuvastatin has the potential to cause side effects, such as muscle soreness, liver damage, and an elevated risk of diabetes.
Before beginning any new drug, including rosuvastatin, it is vital to explore the potential risks and benefits with a healthcare professional.
Global rosuvastatin market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
For the treatment of elevated low-density lipoprotein cholesterol (LDL-C) in adult patients with primary non-familial hyperlipidemia and in adult patients with homozygous familial hypercholesterolemia, Althera Pharmaceuticals received FDA approval for Roszet, a combination of rosuvastatin and ezetimibe.
Additionally, Watson Pharmaceuticals has been given permission to sell generic rosuvastatin calcium in a variety of strengths.
A drug called rosuvastatin can help prevent cardiovascular disease by lowering harmful cholesterol levels. In addition to launching Roszet in 25 European nations, Althera is preparing to do so in additional countries throughout the globe.
In individuals with primary non-familial hyperlipidemia to lower low-density lipoprotein cholesterol (LDL-C), and in people with homozygous familial hypercholesterolemia (HoFH) to lower LDL-C, Roszet is recommended as an adjunct to diet.
The rosuvastatin/ezetimibe dosages for Roszet come in strengths of 5 mg/10 mg, 10 mg/10 mg, 20 mg/10 mg, and 40 mg/10 mg. Roszet has the ability to lower LDL cholesterol by up to 72% at a dose of 40 mg/10 mg and by 64% at a dose of 10 mg/10mg.
